English
简体中文
Total: £ 56.28
Published Date: 2026-01-08 | Pages: 115 | Tables: 113 | Pharma & Healthcare
The global Pleuromutilin market was valued at US$ 98 million in 2025 and is anticipated to reach US$ 137 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pleuromutilin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Pleuromutilin is a broad-spectrum diterpene antibiotic produced by Pleurotus mutilus. It is the precursor of semi-synthetic derivatives of pleuromutilin and can effectively inhibit most Gram-negative bacteria. positive bacteria and some Gram-negative bacteria. Pleuromutilin is a class of antibacterial substances that work by inhibiting the synthesis of protein in bacteria. Pleuromutilins were discovered in the 1950s mainly for veterinary purposes. Pleuromutilin is used for the treatment and prevention of gastrointestinal and respiratory infections caused by different bacterial pathogens in pigs, poultry and rabbits. In our report, our statistical standard is based on 100% content. Active Ingredient Contents is 100%.In 2025, global Pleuromutilin production reached approximately 2557 MT and price is about 38.5 USD/Kg.The average gross profit margin of this product is 13%.
Rising biosecurity expectations and the operational needs of large-scale farming are reinforcing “health management to protect production efficiency” as a durable spending driver. In this environment, clinically familiar pleuromutilin-class solutions remain strategically relevant in key swine respiratory and mycoplasma-related scenarios. In parallel, regulators are advancing prudent use, prescription control, and AMR-oriented oversight, pushing the industry away from extensive use toward standardized, compliant programs. This structural shift favors suppliers that can deliver consistency, registrations, and customer support through a robust compliance and quality system. The veterinary antibacterial segment faces multi-layer constraints: AMR governance tightens prescription compliance, indication boundaries, and intensity management; food safety and residue frameworks raise customer expectations for batch consistency, impurity control, and traceable documentation; and leading animal-health companies increasingly emphasize responsible use and portfolio mix evolution in their annual reporting—signaling a market where compliance execution and solution capability matter as much as price. Collectively, these forces elevate the integrated bar across registration, QA, and channel access. Demand is shifting from “treatment only” to “a component of farm management.” Producers increasingly seek test-informed, segmented medication, better course compliance, and closed-loop recording to reduce systemic outbreak risk. Meanwhile, the implementation of modern veterinary-medicine rules in markets such as the EU further strengthens requirements around prescription justification and process traceability, encouraging more standardized dosage forms and stronger service/tooling around compliant execution. Broker research commonly frames animal-health opportunity around scale-up, compliance upgrading, and substitution/upgrade dynamics—favoring suppliers with dependable delivery and governance-ready operating models. Upstream competitiveness is shaped less by “raw materials” alone and more by reproducible process control and auditable quality systems. For pleuromutilin derivatives, upstream typically spans fermentation-linked nucleus/intermediate sourcing, semi-synthetic reaction inputs (reagents/solvents), and controlled salt formation plus crystallization/purification steps. Veterinary GMP and regulatory expectations convert quality management, documentation, and on-site consistency into non-negotiable requirements, accelerating upstream consolidation toward compliant, scalable, audit-ready operations. In practice, sustainable advantage comes from high-yield scale-up, stable impurity profiles, continuous supply, and audit pass-rates—ultimately reinforcing brand trust and customer stickiness.
This report delivers a comprehensive overview of the global Pleuromutilin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pleuromutilin. The Pleuromutilin market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pleuromutilin market comprehensively. Regional market sizes by Type, by Application, by Salt Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pleuromutilin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sunny Biotech
Hebei Weiyuan
Shandong Shengli
Shandong Lukang
Qingdao Dierman
Qilu Pharma
Huvepharma
Novartis
Vethellas
Elanco
Segment by Type
Premix
API Powder
Segment by Salt Form
Fumarates
Tartrates
Others
Segment by Indication Cluster
Respiratory
Digestiv
Other
by Application
Livestock
Poultry
Consumption by Region
North America
United States
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
Poland
UK
Italy
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Salt Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pleuromutilin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pleuromutilin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Pleuromutilin Market Overview
1.1 Product Definition
1.2 Pleuromutilin by Type
1.2.1 Global Pleuromutilin Market Value by Type: 2025 vs 2032
1.2.2 Premix
1.2.3 API Powder
1.3 Pleuromutilin by Salt Form
1.3.1 Global Pleuromutilin Market Value by Salt Form: 2025 vs 2032
1.3.2 Fumarates
1.3.3 Tartrates
1.3.4 Others
1.4 Pleuromutilin by Indication Cluster
1.4.1 Global Pleuromutilin Market Value by Indication Cluster: 2025 vs 2032
1.4.2 Respiratory
1.4.3 Digestiv
1.4.4 Other
1.5 Pleuromutilin by Application
1.5.1 Global Pleuromutilin Market Value by Application: 2025 vs 2032
1.5.2 Livestock
1.5.3 Poultry
1.6 Global Pleuromutilin Market Size Estimates and Forecasts
1.6.1 Global Pleuromutilin Revenue 2021–2032
1.6.2 Global Pleuromutilin Sales 2021–2032
1.6.3 Global Pleuromutilin Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Pleuromutilin Market Competition by Manufacturers
2.1 Global Pleuromutilin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pleuromutilin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pleuromutilin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pleuromutilin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pleuromutilin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pleuromutilin, Product Types and Applications
2.7 Global Key Manufacturers of Pleuromutilin, Date of Entry into the Industry
2.8 Global Pleuromutilin Market Competitive Situation and Trends
2.8.1 Global Pleuromutilin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pleuromutilin Players Market Share by Revenue
2.8.3 Global Pleuromutilin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pleuromutilin Market Scenario by Region
3.1 Global Pleuromutilin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pleuromutilin Sales by Region: 2021–2032
3.2.1 Global Pleuromutilin Sales by Region: 2021–2026
3.2.2 Global Pleuromutilin Sales by Region: 2027–2032
3.3 Global Pleuromutilin Revenue by Region: 2021–2032
3.3.1 Global Pleuromutilin Revenue by Region: 2021–2026
3.3.2 Global Pleuromutilin Revenue by Region: 2027–2032
3.4 North America Pleuromutilin Market Facts & Figures by Country
3.4.1 North America Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pleuromutilin Sales by Country (2021–2032)
3.4.3 North America Pleuromutilin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 United States
3.4.6 Canada
3.5 Europe Pleuromutilin Market Facts & Figures by Country
3.5.1 Europe Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pleuromutilin Sales by Country (2021–2032)
3.5.3 Europe Pleuromutilin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 Poland
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.5.9 Rest of Europe
3.6 Asia Pacific Pleuromutilin Market Facts & Figures by Region
3.6.1 Asia Pacific Pleuromutilin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pleuromutilin Sales by Region (2021–2032)
3.6.3 Asia Pacific Pleuromutilin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pleuromutilin Market Facts & Figures by Country
3.7.1 Latin America Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pleuromutilin Sales by Country (2021–2032)
3.7.3 Latin America Pleuromutilin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pleuromutilin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pleuromutilin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pleuromutilin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pleuromutilin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pleuromutilin Sales by Type (2021–2032)
4.1.1 Global Pleuromutilin Sales by Type (2021–2026)
4.1.2 Global Pleuromutilin Sales by Type (2027–2032)
4.1.3 Global Pleuromutilin Sales Market Share by Type (2021–2032)
4.2 Global Pleuromutilin Revenue by Type (2021–2032)
4.2.1 Global Pleuromutilin Revenue by Type (2021–2026)
4.2.2 Global Pleuromutilin Revenue by Type (2027–2032)
4.2.3 Global Pleuromutilin Revenue Market Share by Type (2021–2032)
4.3 Global Pleuromutilin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pleuromutilin Sales by Application (2021–2032)
5.1.1 Global Pleuromutilin Sales by Application (2021–2026)
5.1.2 Global Pleuromutilin Sales by Application (2027–2032)
5.1.3 Global Pleuromutilin Sales Market Share by Application (2021–2032)
5.2 Global Pleuromutilin Revenue by Application (2021–2032)
5.2.1 Global Pleuromutilin Revenue by Application (2021–2026)
5.2.2 Global Pleuromutilin Revenue by Application (2027–2032)
5.2.3 Global Pleuromutilin Revenue Market Share by Application (2021–2032)
5.3 Global Pleuromutilin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sunny Biotech
6.1.1 Sunny Biotech Company Information
6.1.2 Sunny Biotech Description and Business Overview
6.1.3 Sunny Biotech Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sunny Biotech Pleuromutilin Product Portfolio
6.1.5 Sunny Biotech Recent Developments/Updates
6.2 Hebei Weiyuan
6.2.1 Hebei Weiyuan Company Information
6.2.2 Hebei Weiyuan Description and Business Overview
6.2.3 Hebei Weiyuan Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hebei Weiyuan Pleuromutilin Product Portfolio
6.2.5 Hebei Weiyuan Recent Developments/Updates
6.3 Shandong Shengli
6.3.1 Shandong Shengli Company Information
6.3.2 Shandong Shengli Description and Business Overview
6.3.3 Shandong Shengli Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Shandong Shengli Pleuromutilin Product Portfolio
6.3.5 Shandong Shengli Recent Developments/Updates
6.4 Shandong Lukang
6.4.1 Shandong Lukang Company Information
6.4.2 Shandong Lukang Description and Business Overview
6.4.3 Shandong Lukang Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shandong Lukang Pleuromutilin Product Portfolio
6.4.5 Shandong Lukang Recent Developments/Updates
6.5 Qingdao Dierman
6.5.1 Qingdao Dierman Company Information
6.5.2 Qingdao Dierman Description and Business Overview
6.5.3 Qingdao Dierman Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qingdao Dierman Pleuromutilin Product Portfolio
6.5.5 Qingdao Dierman Recent Developments/Updates
6.6 Qilu Pharma
6.6.1 Qilu Pharma Company Information
6.6.2 Qilu Pharma Description and Business Overview
6.6.3 Qilu Pharma Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Qilu Pharma Pleuromutilin Product Portfolio
6.6.5 Qilu Pharma Recent Developments/Updates
6.7 Huvepharma
6.7.1 Huvepharma Company Information
6.7.2 Huvepharma Description and Business Overview
6.7.3 Huvepharma Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Huvepharma Pleuromutilin Product Portfolio
6.7.5 Huvepharma Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Novartis Pleuromutilin Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Vethellas
6.9.1 Vethellas Company Information
6.9.2 Vethellas Description and Business Overview
6.9.3 Vethellas Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Vethellas Pleuromutilin Product Portfolio
6.9.5 Vethellas Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Company Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Pleuromutilin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Elanco Pleuromutilin Product Portfolio
6.10.5 Elanco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pleuromutilin Industry Chain Analysis
7.2 Pleuromutilin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pleuromutilin Production Mode & Process Analysis
7.4 Pleuromutilin Sales and Marketing
7.4.1 Pleuromutilin Sales Channels
7.4.2 Pleuromutilin Distributors
7.5 Pleuromutilin Customer Analysis
8 Pleuromutilin Market Dynamics
8.1 Pleuromutilin Industry Trends
8.2 Pleuromutilin Market Drivers
8.3 Pleuromutilin Market Challenges
8.4 Pleuromutilin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pleuromutilin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pleuromutilin Market Value by Salt Form (US$ Million), 2025 vs 2032
Table 3. Global Pleuromutilin Market Value by Indication Cluster (US$ Million), 2025 vs 2032
Table 4. Global Pleuromutilin Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Pleuromutilin Market Competitive Situation by Manufacturers in 2025
Table 6. Global Pleuromutilin Sales (MT) of Key Manufacturers (2021–2026)
Table 7. Global Pleuromutilin Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Pleuromutilin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Pleuromutilin Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Pleuromutilin Average Price (US$/Kg) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Pleuromutilin, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Pleuromutilin, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Pleuromutilin, Product Types and Applications
Table 14. Global Key Manufacturers of Pleuromutilin, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Pleuromutilin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pleuromutilin Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Pleuromutilin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Pleuromutilin Sales by Region (MT), 2021–2026
Table 20. Global Pleuromutilin Sales Market Share by Region (2021–2026)
Table 21. Global Pleuromutilin Sales by Region (MT), 2027–2032
Table 22. Global Pleuromutilin Sales Market Share by Region (2027–2032)
Table 23. Global Pleuromutilin Revenue by Region (US$ Million), 2021–2026
Table 24. Global Pleuromutilin Revenue Market Share by Region (2021–2026)
Table 25. Global Pleuromutilin Revenue by Region (US$ Million), 2027–2032
Table 26. Global Pleuromutilin Revenue Market Share by Region (2027–2032)
Table 27. North America Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Pleuromutilin Sales by Country (MT), 2021–2026
Table 29. North America Pleuromutilin Sales by Country (MT), 2027–2032
Table 30. North America Pleuromutilin Revenue by Country (US$ Million), 2021–2026
Table 31. North America Pleuromutilin Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Pleuromutilin Sales by Country (MT), 2021–2026
Table 34. Europe Pleuromutilin Sales by Country (MT), 2027–2032
Table 35. Europe Pleuromutilin Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Pleuromutilin Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Pleuromutilin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Pleuromutilin Sales by Region (MT), 2021–2026
Table 39. Asia Pacific Pleuromutilin Sales by Region (MT), 2027–2032
Table 40. Asia Pacific Pleuromutilin Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Pleuromutilin Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Pleuromutilin Sales by Country (MT), 2021–2026
Table 44. Latin America Pleuromutilin Sales by Country (MT), 2027–2032
Table 45. Latin America Pleuromutilin Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Pleuromutilin Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Pleuromutilin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Pleuromutilin Sales by Country (MT), 2021–2026
Table 49. Middle East and Africa Pleuromutilin Sales by Country (MT), 2027–2032
Table 50. Middle East and Africa Pleuromutilin Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Pleuromutilin Revenue by Country (US$ Million), 2027–2032
Table 52. Global Pleuromutilin Sales (MT) by Type (2021–2026)
Table 53. Global Pleuromutilin Sales (MT) by Type (2027–2032)
Table 54. Global Pleuromutilin Sales Market Share by Type (2021–2026)
Table 55. Global Pleuromutilin Sales Market Share by Type (2027–2032)
Table 56. Global Pleuromutilin Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Pleuromutilin Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Pleuromutilin Revenue Market Share by Type (2021–2026)
Table 59. Global Pleuromutilin Revenue Market Share by Type (2027–2032)
Table 60. Global Pleuromutilin Price (US$/Kg) by Type (2021–2026)
Table 61. Global Pleuromutilin Price (US$/Kg) by Type (2027–2032)
Table 62. Global Pleuromutilin Sales (MT) by Application (2021–2026)
Table 63. Global Pleuromutilin Sales (MT) by Application (2027–2032)
Table 64. Global Pleuromutilin Sales Market Share by Application (2021–2026)
Table 65. Global Pleuromutilin Sales Market Share by Application (2027–2032)
Table 66. Global Pleuromutilin Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Pleuromutilin Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Pleuromutilin Revenue Market Share by Application (2021–2026)
Table 69. Global Pleuromutilin Revenue Market Share by Application (2027–2032)
Table 70. Global Pleuromutilin Price (US$/Kg) by Application (2021–2026)
Table 71. Global Pleuromutilin Price (US$/Kg) by Application (2027–2032)
Table 72. Sunny Biotech Company Information
Table 73. Sunny Biotech Description and Business Overview
Table 74. Sunny Biotech Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 75. Sunny Biotech Pleuromutilin Product
Table 76. Sunny Biotech Recent Developments/Updates
Table 77. Hebei Weiyuan Company Information
Table 78. Hebei Weiyuan Description and Business Overview
Table 79. Hebei Weiyuan Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 80. Hebei Weiyuan Pleuromutilin Product
Table 81. Hebei Weiyuan Recent Developments/Updates
Table 82. Shandong Shengli Company Information
Table 83. Shandong Shengli Description and Business Overview
Table 84. Shandong Shengli Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 85. Shandong Shengli Pleuromutilin Product
Table 86. Shandong Shengli Recent Developments/Updates
Table 87. Shandong Lukang Company Information
Table 88. Shandong Lukang Description and Business Overview
Table 89. Shandong Lukang Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 90. Shandong Lukang Pleuromutilin Product
Table 91. Shandong Lukang Recent Developments/Updates
Table 92. Qingdao Dierman Company Information
Table 93. Qingdao Dierman Description and Business Overview
Table 94. Qingdao Dierman Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 95. Qingdao Dierman Pleuromutilin Product
Table 96. Qingdao Dierman Recent Developments/Updates
Table 97. Qilu Pharma Company Information
Table 98. Qilu Pharma Description and Business Overview
Table 99. Qilu Pharma Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 100. Qilu Pharma Pleuromutilin Product
Table 101. Qilu Pharma Recent Developments/Updates
Table 102. Huvepharma Company Information
Table 103. Huvepharma Description and Business Overview
Table 104. Huvepharma Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 105. Huvepharma Pleuromutilin Product
Table 106. Huvepharma Recent Developments/Updates
Table 107. Novartis Company Information
Table 108. Novartis Description and Business Overview
Table 109. Novartis Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 110. Novartis Pleuromutilin Product
Table 111. Novartis Recent Developments/Updates
Table 112. Vethellas Company Information
Table 113. Vethellas Description and Business Overview
Table 114. Vethellas Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 115. Vethellas Pleuromutilin Product
Table 116. Vethellas Recent Developments/Updates
Table 117. Elanco Company Information
Table 118. Elanco Description and Business Overview
Table 119. Elanco Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 120. Elanco Pleuromutilin Product
Table 121. Elanco Recent Developments/Updates
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Pleuromutilin Distributors List
Table 125. Pleuromutilin Customers List
Table 126. Pleuromutilin Market Trends
Table 127. Pleuromutilin Market Drivers
Table 128. Pleuromutilin Market Challenges
Table 129. Pleuromutilin Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pleuromutilin
Figure 2. Global Pleuromutilin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pleuromutilin Market Share by Type: 2025 & 2032
Figure 4. Premix Product Picture
Figure 5. API Powder Product Picture
Figure 6. Global Pleuromutilin Market Value by Salt Form (US$ Million), 2021–2032
Figure 7. Global Pleuromutilin Market Share by Salt Form: 2025 vs 2032
Figure 8. Fumarates Product Picture
Figure 9. Tartrates Product Picture
Figure 10. Others Product Picture
Figure 11. Global Pleuromutilin Market Value by Indication Cluster (US$ Million), 2021–2032
Figure 12. Global Pleuromutilin Market Share by Indication Cluster: 2025 vs 2032
Figure 13. Respiratory Product Picture
Figure 14. Digestiv Product Picture
Figure 15. Other Product Picture
Figure 16. Global Pleuromutilin Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Pleuromutilin Market Share by Application: 2025 & 2032
Figure 18. Livestock
Figure 19. Poultry
Figure 20. Global Pleuromutilin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Pleuromutilin Market Size (US$ Million), 2021–2032
Figure 22. Global Pleuromutilin Sales (MT), 2021–2032
Figure 23. Global Pleuromutilin Average Price (US$/Kg), 2021–2032
Figure 24. Pleuromutilin Report Years Considered
Figure 25. Pleuromutilin Sales Share by Manufacturers in 2025
Figure 26. Global Pleuromutilin Revenue Share by Manufacturers in 2025
Figure 27. Top 5 and Top 10 Global Pleuromutilin Players: Market Share by Revenue in Pleuromutilin in 2025
Figure 28. Pleuromutilin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 29. Global Pleuromutilin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 30. North America Pleuromutilin Sales Market Share by Country (2021–2032)
Figure 31. North America Pleuromutilin Revenue Market Share by Country (2021–2032)
Figure 32. United States Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. United States Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Pleuromutilin Sales Market Share by Country (2021–2032)
Figure 36. Europe Pleuromutilin Revenue Market Share by Country (2021–2032)
Figure 37. Germany Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Poland Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. UK Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Rest of Europe Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Pleuromutilin Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Pleuromutilin Revenue Market Share by Region (2021–2032)
Figure 45. China Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Pleuromutilin Sales Market Share by Country (2021–2032)
Figure 53. Latin America Pleuromutilin Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Middle East and Africa Pleuromutilin Sales Market Share by Country (2021–2032)
Figure 58. Middle East and Africa Pleuromutilin Revenue Market Share by Country (2021–2032)
Figure 59. Turkey Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Saudi Arabia Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. UAE Pleuromutilin Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Global Sales Market Share of Pleuromutilin by Type (2021–2032)
Figure 63. Global Revenue Market Share of Pleuromutilin by Type (2021–2032)
Figure 64. Global Pleuromutilin Price (US$/Kg) by Type (2021–2032)
Figure 65. Global Sales Market Share of Pleuromutilin by Application (2021–2032)
Figure 66. Global Revenue Market Share of Pleuromutilin by Application (2021–2032)
Figure 67. Global Pleuromutilin Price (US$/Kg) by Application (2021–2032)
Figure 68. Pleuromutilin Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
